Association between electrocardiographic features and mortality in COVID‐19 patients
…, S Singh, M Taha, J Ghuman… - Annals of …, 2021 - Wiley Online Library
Background Cardiovascular events have been reported in the setting of coronavirus disease‐19
(COVID‐19). It has been hypothesized that systemic inflammation may aggravate …
(COVID‐19). It has been hypothesized that systemic inflammation may aggravate …
[HTML][HTML] Cardiac adverse events of immune checkpoint inhibitors in oncology patients: a systematic review and meta-analysis
…, BD Beutler, MB Ulanja, J Ghuman… - World Journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Immune checkpoint inhibitors (ICIs) are novel therapeutic agents used for
various types of cancer. ICIs have revolutionized cancer treatment and improved clinical …
various types of cancer. ICIs have revolutionized cancer treatment and improved clinical …
[HTML][HTML] SVEAT score outperforms HEART score in patients admitted to a chest pain observation unit
…, BD Beutler, M Awad, A Hanfy, J Ghuman… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Timely and accurate identification of subgroup at risk for major adverse
cardiovascular events among patients presenting with acute chest pain remains a challenge. …
cardiovascular events among patients presenting with acute chest pain remains a challenge. …
[PDF][PDF] Sociodemographic predictors of outcomes in COVID-19: examining the impact of ethnic disparities in Northern Nevada
…, BD Beutler, M Awad, Z Kanji, S Mahboob, J Ghuman… - Cureus, 2021 - cureus.com
Background On March 11, 2020, the World Health Organization declared coronavirus
disease-19 (COVID-19) a pandemic. Nearly five million individuals have since been diagnosed …
disease-19 (COVID-19) a pandemic. Nearly five million individuals have since been diagnosed …
[PDF][PDF] Atorvastatin-induced refractory thrombocytopenia
J Ghuman, NT Manasewitsch, J Ghuman… - Cureus, 2021 - cureus.com
Drug-induced thrombocytopenia is rarely associated with statin medications. We describe
the case of a 69-year-old woman who developed refractory thrombocytopenia following …
the case of a 69-year-old woman who developed refractory thrombocytopenia following …
[PDF][PDF] Computed tomographic evaluation of mediastinal masses/lesions with contrast enhancement and correlation with pathological diagnosis-a study of 120 cases
H Kaur, P Tiwari, P Dugg, J Ghuman… - Journal of Biomedical …, 2014 - researchgate.net
Objective: The study was conducted to diagnose the mediastinal lesions/masses by computed
tomographic on contrast enhanced scans and findings were compared with pathological …
tomographic on contrast enhanced scans and findings were compared with pathological …
[HTML][HTML] Ponatinib-associated panniculitis: case report and review of the literature
D Antwi-Amoabeng, J Ghuman, J Ghuman… - Cancer Treatment and …, 2021 - Elsevier
Ponatinib is a tyrosine kinase inhibitor (TKI) approved for the treatment of Philadelphia
chromosome-positive chronic myelogenous leukemia and acute lymphoblastic leukemia. …
chromosome-positive chronic myelogenous leukemia and acute lymphoblastic leukemia. …
[PDF][PDF] Sociodemographic Disparities in Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists Prescription Patterns Among …
…, BD Beutler, J Ghuman, MB Ulanja, J Ghuman… - Cureus, 2024 - cureus.com
Sodium-glucose co-transporter-2 inhibitors (SGLT2Is) and glucagon-like peptide-1 receptor
agonists (GLP-1RAs) are novel antihyperglycemic agents that reduce cardiovascular …
agonists (GLP-1RAs) are novel antihyperglycemic agents that reduce cardiovascular …
Cardiac Adverse Events of Immune Checkpoint Inhibitors in Oncology Patients: A Systematic Review and Meta-Analysis
…, BD Beutler, MB Ulanja, J Ghuman… - medRxiv, 2020 - medrxiv.org
Background Immune checkpoint inhibitors (ICIs) are novel therapeutic agents used for
various types of cancer. ICIs have revolutionized cancer treatment and improved clinical …
various types of cancer. ICIs have revolutionized cancer treatment and improved clinical …
PREVALENCE OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AMONG PATIENTS HOSPITALIZED FOR MYOCARDIAL INFARCTION …
…, J Ghuman, N Agrawal, J Ghuman… - Journal of the American …, 2021 - jacc.org
Background Monoclonal gammopathy of undetermined significance (MGUS) is the most
common plasma cell dyscrasia. It is linked to cardiac amyloidosis, hyperviscosity, and may …
common plasma cell dyscrasia. It is linked to cardiac amyloidosis, hyperviscosity, and may …
